Patent · US Active

Formulations of a compound modulating kinases

US11103505B2 · kind B2 · utility

1Cited by

82References

19Claims

0Family size

Assignee

Plexxikon Inc. · US

Inventors

Hamid Rezaei · Berkeley, US
Marika Nespi · Berkeley, US
Prabha N. Ibrahim · Mountain View, US
Gary Conard Visor · Rue de l'Église, US

Key dates

Filing date	Oct 26, 2018
Grant date	Aug 31, 2021
Priority date	—
Expiry date	Oct 26, 2038

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K9/10
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided are solid dispersions of Compound I having the formula: wherein Compound I is substantially amorphous, methods of manufacturing said solid dispersions, and methods of using said solid dispersions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.